SPAST and hereditary spastic paraplegia: Loss-of-function mouse SPG4-HSP models show motor behavior deficits and axon trafficking impairment; heterozygous mice show very mild phenotypes compared with the homozygous ones, further supporting a dosage effect (22, 23).